These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 26318692)
1. Rituximab as an alternative for patients with severe systemic vasculitis refractory to conventional therapy: report of seven cases and literature review. da Silva LS; de Campos KV; de Melo AK; de Brito DC; Braz AS; Freire EA Rev Bras Reumatol; 2015; 55(6):531-5. PubMed ID: 26318692 [TBL] [Abstract][Full Text] [Related]
2. S1. Rituximab for ANCA-associated vasculitis: the experience in the United States. Clain JM; Specks U Presse Med; 2013 Apr; 42(4 Pt 2):530-2. PubMed ID: 23477713 [No Abstract] [Full Text] [Related]
3. Treatment of ANCA-associated vasculitis: new therapies and a look at old entities. Zand L; Specks U; Sethi S; Fervenza FC Adv Chronic Kidney Dis; 2014 Mar; 21(2):182-93. PubMed ID: 24602467 [TBL] [Abstract][Full Text] [Related]
4. Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients. Charles P; Néel A; Tieulié N; Hot A; Pugnet G; Decaux O; Marie I; Khellaf M; Kahn JE; Karras A; Ziza JM; Deligny C; Tchérakian C; Guillevin L; Rheumatology (Oxford); 2014 Mar; 53(3):532-9. PubMed ID: 24282319 [TBL] [Abstract][Full Text] [Related]
12. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. Jones RB; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh D; Walsh M; Westman K; Jayne DR; N Engl J Med; 2010 Jul; 363(3):211-20. PubMed ID: 20647198 [TBL] [Abstract][Full Text] [Related]
13. Rituximab in Treatment of Children with Refractory Vasculitis and Systemic Lupus Erythematosus - Single Center Experience in Croatia. Sršen S; Frković M; Malčić I; Jelušić M Acta Dermatovenerol Croat; 2020 Aug; 28(2):63-69. PubMed ID: 32876030 [TBL] [Abstract][Full Text] [Related]
14. Advances in therapy for ANCA-associated vasculitis. Geetha D; Seo P Curr Rheumatol Rep; 2012 Dec; 14(6):509-15. PubMed ID: 22895899 [TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis. Alberici F; Smith RM; Jones RB; Roberts DM; Willcocks LC; Chaudhry A; Smith KG; Jayne DR Rheumatology (Oxford); 2015 Jul; 54(7):1153-60. PubMed ID: 25477054 [TBL] [Abstract][Full Text] [Related]
16. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab. Cartin-Ceba R; Fervenza FC; Specks U Curr Opin Rheumatol; 2012 Jan; 24(1):15-23. PubMed ID: 22089095 [TBL] [Abstract][Full Text] [Related]
17. [The role of rituximab in the treatment of ANCA-associated systemic vasculitis]. Roccatello D; Vangelista A; Pani A G Ital Nefrol; 2011; 28(5):474-88. PubMed ID: 22028261 [TBL] [Abstract][Full Text] [Related]
18. Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement. Geetha D; Specks U; Stone JH; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Fessler BJ; Ding L; Tchao NK; Ikle D; Jepson B; Brunetta P; Fervenza FC; J Am Soc Nephrol; 2015 Apr; 26(4):976-85. PubMed ID: 25381429 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID). Roll P; Ostermeier E; Haubitz M; Lovric S; Unger L; Holle J; Kötter I; Henes JC; Bergner R; Rubbert-Roth A; Specker C; Schulze-Koops H; Müller-Ladner U; Fleck M; Burmester GR; Hiepe F; Heitmann S; Aringer M; Fischer-Betz R; Dörner T; Tony HP J Rheumatol; 2012 Nov; 39(11):2153-6. PubMed ID: 22984269 [TBL] [Abstract][Full Text] [Related]
20. Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis. van Daalen EE; Rizzo R; Kronbichler A; Wolterbeek R; Bruijn JA; Jayne DR; Bajema IM; Rahmattulla C Ann Rheum Dis; 2017 Jun; 76(6):1064-1069. PubMed ID: 27899372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]